These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 25530915

  • 21. Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring.
    Maye JE, Betensky RA, Gidicsin CM, Locascio J, Becker JA, Pepin L, Carmasin J, Rentz DM, Marshall GA, Blacker D, Sperling RA, Johnson KA.
    Neurobiol Aging; 2016 Apr; 40():61-67. PubMed ID: 26973104
    [Abstract] [Full Text] [Related]

  • 22. Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.
    Honea RA, Swerdlow RH, Vidoni ED, Burns JM.
    Neurology; 2011 Mar 01; 76(9):822-9. PubMed ID: 21357834
    [Abstract] [Full Text] [Related]

  • 23. Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
    Li WW, Shen YY, Tian DY, Bu XL, Zeng F, Liu YH, Chen Y, Yao XQ, Li HY, Chen DW, Zhou FY, Yang H, Li QM, Bao WQ, Guan YH, Zhou HD, Jin RB, Wang YJ.
    J Alzheimers Dis; 2019 Mar 01; 69(1):169-178. PubMed ID: 30958377
    [Abstract] [Full Text] [Related]

  • 24. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL, AIBL Research Group.
    Brain; 2012 Jul 01; 135(Pt 7):2126-39. PubMed ID: 22628162
    [Abstract] [Full Text] [Related]

  • 25. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.
    Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246
    [Abstract] [Full Text] [Related]

  • 26. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B.
    Meyer PT, Hellwig S, Amtage F, Rottenburger C, Sahm U, Reuland P, Weber WA, Hüll M.
    J Nucl Med; 2011 Mar 15; 52(3):393-400. PubMed ID: 21321269
    [Abstract] [Full Text] [Related]

  • 27. Metabolic Syndrome and Amyloid Accumulation in the Aging Brain.
    Gomez G, Beason-Held LL, Bilgel M, An Y, Wong DF, Studenski S, Ferrucci L, Resnick SM.
    J Alzheimers Dis; 2018 Mar 15; 65(2):629-639. PubMed ID: 30103324
    [Abstract] [Full Text] [Related]

  • 28. Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease.
    Bunai T, Kakimoto A, Yoshikawa E, Terada T, Ouchi Y.
    J Alzheimers Dis; 2019 Mar 15; 69(2):529-538. PubMed ID: 31104023
    [Abstract] [Full Text] [Related]

  • 29. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.
    Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Takahashi M, Nakagawara J, Iida H, Kishimoto T, Nagatsuka K.
    Neuroimage Clin; 2017 Mar 15; 13():209-214. PubMed ID: 28003959
    [Abstract] [Full Text] [Related]

  • 30. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D.
    J Alzheimers Dis; 2017 Mar 15; 59(2):603-614. PubMed ID: 28671117
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases.
    Daerr S, Brendel M, Zach C, Mille E, Schilling D, Zacherl MJ, Bürger K, Danek A, Pogarell O, Schildan A, Patt M, Barthel H, Sabri O, Bartenstein P, Rominger A.
    Neuroimage Clin; 2017 Mar 15; 14():77-86. PubMed ID: 28138429
    [Abstract] [Full Text] [Related]

  • 32. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.
    Rabinovici GD, Rosen HJ, Alkalay A, Kornak J, Furst AJ, Agarwal N, Mormino EC, O'Neil JP, Janabi M, Karydas A, Growdon ME, Jang JY, Huang EJ, Dearmond SJ, Trojanowski JQ, Grinberg LT, Gorno-Tempini ML, Seeley WW, Miller BL, Jagust WJ.
    Neurology; 2011 Dec 06; 77(23):2034-42. PubMed ID: 22131541
    [Abstract] [Full Text] [Related]

  • 33. Voxel-wise hemispheric Amyloid Asymmetry and its association with cerebral metabolism and grey matter density in cognitively normal older adults.
    Jayaprakash HJ, Mizuno A, Snitz BE, Cohen AD, Klunk WE, Aizenstein HJ, Karim HT.
    medRxiv; 2024 Mar 06. PubMed ID: 38496561
    [Abstract] [Full Text] [Related]

  • 34. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.
    Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, De Santi S, de Leon MJ.
    Proc Natl Acad Sci U S A; 2007 Nov 27; 104(48):19067-72. PubMed ID: 18003925
    [Abstract] [Full Text] [Related]

  • 35. Amyloid imaging in Alzheimer's disease and other dementias.
    Fodero-Tavoletti MT, Cappai R, McLean CA, Pike KE, Adlard PA, Cowie T, Connor AR, Masters CL, Rowe CC, Villemagne VL.
    Brain Imaging Behav; 2009 Sep 27; 3(3):246-61. PubMed ID: 22005989
    [Abstract] [Full Text] [Related]

  • 36. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.
    Brain; 2006 Nov 27; 129(Pt 11):2856-66. PubMed ID: 16854944
    [Abstract] [Full Text] [Related]

  • 37. (18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease.
    Mosconi L, Tsui WH, Pupi A, De Santi S, Drzezga A, Minoshima S, de Leon MJ.
    J Nucl Med; 2007 Jul 27; 48(7):1129-34. PubMed ID: 17574982
    [Abstract] [Full Text] [Related]

  • 38. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
    Omachi Y, Ito K, Arima K, Matsuda H, Nakata Y, Sakata M, Sato N, Nakagome K, Motohashi N.
    Psychiatry Clin Neurosci; 2015 Dec 27; 69(12):741-51. PubMed ID: 26085054
    [Abstract] [Full Text] [Related]

  • 39. Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier.
    Matthews DC, Lukic AS, Andrews RD, Wernick MN, Strother SC, Schmidt ME, Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement (N Y); 2022 Dec 27; 8(1):e12325. PubMed ID: 35846158
    [Abstract] [Full Text] [Related]

  • 40. High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study.
    Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Kosaka J, Kudo T, Iida H, Kishimoto T, Nagatsuka K.
    Int J Geriatr Psychiatry; 2016 Aug 27; 31(8):920-8. PubMed ID: 26766490
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.